Recently, the Archives of Toxicology have started a series of review articles about xenobiotic metabolizing enzymes, systematically addressing nomenclature and gene evolution, catalytic mechanisms, toxicological relevance, and polymorphisms (Bolt and Hengstler 2008) . Olavi Pelkonen has already reviewed cytochrome P450 enzymes (Pelkonen et al. 2008) and CP Strassburg and TO Lankisch have contributed comprehensive articles about UDP-glucuronosyltransferases (Strassburg et al. 2008; Lankisch et al. 2008) .
We are happy that Michael Arand, Annette Cronin and Martina Decker from the University of Zürich continued our series of review articles about drug-metabolizing enzymes with an excellent contribution about mammalian epoxide hydrolases (Decker et al. 2009, this issue) . Traditionally, epoxide hydrolases are known as primarily detoxifying enzymes that catalyze the hydrolysis of epoxides (Hengstler et al. 1998) . Importantly, epoxide hydrolases act by a two-step reaction, which has some important implications. In a Wrst step, two tyrosines in the catalytic center of the enzyme bind the epoxide by hydrogen bonding to the ring oxygen, and an aspartic acid residue attacks a carbon atom of the oxirane ring (Oesch et al. 2000 (Oesch et al. , 2001 . Simultaneously, the bond of this carbon is released and an ester intermediate is formed. In a second step, the covalent intermediate is hydrolyzed and the detoxiWed product of the epoxide hydrolase reaction is released. Importantly, the formation of the ester intermediate (step 1) proceeds by three orders of magnitudes faster than the subsequent hydrolysis (step 2). Therefore, epoxide hydrolases may act like a molecular sponge that binds and inactivates dangerous epoxides rapidly, whereas the subsequent release of the product occurs only slowly (Oesch et al. 2001 ). This explains why epoxide hydrolases can keep tissue concentrations of free epoxides very low up to concentrations of epoxides where the epoxide hydrolases are titrated out leading to a sudden burst of the epoxides. This sponge eVect contributes to threshold mechanisms observed for some genotoxic epoxides (Oesch et al. 2001; Hengstler et al. 2003 Hengstler et al. , 1997 .
However, in their current review Decker et al. (2009) show that mammalian epoxide hydrolases are more than just a sponge for genotoxic waste. The authors collected convincing evidence that epoxide hydrolases are also involved in control of the following functions:
• blood pressure • inXammation and nociception • participation of signal transduction processes relevant for cell proliferation • control of adult respiratory distress syndrome and multiorgan failure.
Cutting edge topics of our journal are drug metabolism (Borza et al. 2008; Hengstler and Bolt 2008; Glahn et al. 2008; Gundert-Remy and Hengstler 2008; Binner et al. 2008; Naraharisetti et al. 2008; Rudolf et al. 2008; Fisher et al. 2008; Mitchell et al. 2007 ) control of genotoxic intermediates (Adam and Laufs 2008; Verstraeten et al. 2008; Puntel et al. 2008; Settels et al. 2008; Lindström et al. 2008; Wong et al. 2008 ) and in vitro systems to simulate in vivo metabolism (Schug et al. 2008; Hewitt et al. 2007; Sugihara et al. 2008) . Therefore, epoxide hydrolases represent a traditional focus of our journal (Srivastava et al. 2008; Cornelis et al. 2007; Wenghoefer et al. 2003 et al. 1989; PaciWci et al. 1988) . What makes the current review so attractive is its demonstration that an enzyme family traditionally believed to be limited to detoxifying functions also plays a relevant role in processes such as vasodilation, inXammation, and proliferation. 
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